市場調查報告書
商品編碼
1500517
獸醫診斷設備市場:按測試類型、產品類型、動物種類和最終用戶 - 2024-2030 年全球預測Veterinary Diagnostic Equipment Market by Testings Type (Bacteriology, Clinical Chemistry Test, Diagnostic Imaging), Product Type (Consumables, Reagents & Kits, Instruments & Devices), Species, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年獸醫診斷設備市場規模為27.6億美元,2024年達29.6億美元,預計2030年將達到45.5億美元,複合年成長率為7.36%。
獸醫診斷設備由專門設計用於診斷動物疾病、狀況和整體健康狀況的各種工具和系統組成。該設備在獸醫學中發揮著重要作用,獸醫和獸醫技術人員可以準確評估和監測寵物、牲畜和其他動物的健康狀況。這些診斷工具採用先進技術,從X光設備和超音波設備等診斷影像設備到血液分析儀和PCR機等臨床檢測設備。這些設備提供的準確及時的診斷對於制定有效的治療計劃和確保動物健康至關重要。寵物擁有量的增加和寵物照護費用的增加,以及動物疾病盛行率的上升,正在推動對獸醫診斷設備的需求。此外,人類消費的動物源產品的增加強調了牲畜健康的重要性,並增加了對有效診斷解決方案的需求。然而,先進診斷設備的高成本和新興市場的低知名度可能會阻礙市場成長。也就是說,分子診斷、免疫診斷分析和即時護理設備的技術創新是探索和擴展的成熟領域,並可能為市場成長開闢新的途徑。
主要市場統計 | |
---|---|
基準年[2023] | 27.6億美元 |
預測年份 [2024] | 29.6億美元 |
預測年份 [2030] | 45.5億美元 |
複合年成長率(%) | 7.36% |
區域洞察
美洲地區代表了獸醫診斷設備的強勁市場。由於寵物擁有率高、動物保健支出高以及主要市場參與者的強大影響力,美國在市場規模和技術進步方面處於領先地位。由於動物健康意識的提高和寵物主人可支配收入的增加,包括巴西和墨西哥在內的拉丁美洲國家正在經歷該行業的成長。 EMEA(歐洲、中東和非洲)地區呈現出多元化的市場格局。歐洲因其高標準的獸醫護理、嚴格的動物健康法規和大量的研發投資而在市場成熟度方面處於領先地位。中東和非洲地區是一個具有高成長潛力的新興市場,受到寵物擁有率上升、畜牧業擴張以及動物健康意識不斷增強的支持。由於寵物擁有率上升、畜牧業擴張以及獸醫醫療保健支出增加,亞太地區獸醫診斷設備市場正在快速成長。中國、印度、日本和澳洲等國家正在引領該地區的成長。該市場的特點是先進技術和基本診斷工具的結合,滿足都市區地區的多樣化需求。該地區動物健康基礎設施和獸醫服務投資的增加,以及提供廣泛診斷解決方案的國內和國際公司的進入,正在進一步推動市場成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在獸醫診斷設備市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對獸醫診斷設備市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在獸醫診斷設備市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[199 Pages Report] The Veterinary Diagnostic Equipment Market size was estimated at USD 2.76 billion in 2023 and expected to reach USD 2.96 billion in 2024, at a CAGR 7.36% to reach USD 4.55 billion by 2030.
Veterinary Diagnostic Equipment comprises a diverse range of tools and systems designed specifically for diagnosing diseases, conditions, and the overall health status of animals. This equipment plays a crucial role in the veterinary sector by enabling veterinarians and veterinary technicians to accurately assess & monitor the health of pets, livestock, and other animals. Utilizing advanced technology, these diagnostic tools range from imaging equipment, such as X-ray & ultrasound machines, to clinical laboratory devices, such as blood analyzers and PCR machines. The precise and timely diagnoses provided by these instruments are essential for effective treatment planning and ensuring the well-being of animals. Increasing pet adoption and expenditure on pet care, coupled with a rising prevalence rate of diseases among animals, has increased the need for veterinary diagnostic equipment. Furthermore, the growth of animal-derived products for human consumption underlines the importance of livestock health, amplifying the need for efficient diagnostic solutions. However, the high cost of advanced diagnostic equipment and lack of awareness in emerging markets may hamper the market growth. Nevertheless, innovations in molecular diagnostics, immune-diagnostic assays, and point-of-care devices represent areas ripe for exploration and expansion, potentially opening new avenues for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.76 billion |
Estimated Year [2024] | USD 2.96 billion |
Forecast Year [2030] | USD 4.55 billion |
CAGR (%) | 7.36% |
Regional Insights
The Americas region exhibits a robust market for veterinary diagnostic equipment. The United States leads in terms of market size and technological advancements, driven by high pet ownership rates, substantial veterinary healthcare expenditures, and a strong presence of leading market players. Countries in Latin America including Brazil , Mexico are experiencing growth in this sector due to increasing awareness about animal health and rising disposable incomes among pet owners. The EMEA region presents a diverse market landscape. Europe is at the forefront in terms of market maturity, driven by high standards of veterinary care, stringent animal health regulations, and significant R&D investments. The MEA region is an emerging market with potential for high growth, supported by increasing pet adoption rates, expanding livestock sectors, and growing awareness about animal health. The Asia Pacific region showcases rapid growth in the veterinary diagnostic equipment market, attributed to rising pet ownership, expanding livestock industries, and increasing expenditures on animal healthcare. Countries including China, India, Japan, and Australia are leading the growth in this region. The market is characterized by a mix of advanced technologies and basic diagnostic tools, catering to diverse needs across urban and rural areas. Growing investments in animal health infrastructure and veterinary services in the region and the expansion of local and international companies in the region, offering a wide range of diagnostic solutions, are further supporting the growth of the market.
Market Insights
The market dynamics represent an ever-changing landscape of the Veterinary Diagnostic Equipment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Veterinary Diagnostic Equipment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Veterinary Diagnostic Equipment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Center Point Bio-Tech's Launch of Novel Veterinary Diagnostic System Exceeds Expectations
Center Point Bio-Tech, LLC launched AlphaION, a veterinary diagnostic system that combines lab automation with artificial intelligence to enhance workflow in veterinary practices, offering comprehensive testing capabilities through its modular design, including blood, fecal, urine, and bacterial tests. AlphaION distinguishes itself as a diagnostic system that integrates Surface Acoustic Wave (SAW) technology for precise biomarker measurement and introduces in-clinic automation for bacterial culture and sensitivity testing, addressing common issues such as false negatives and testing delays associated with external labs. [Published On: 2024-01-24]
Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory
Antech expanded its UK laboratory network by opening a new, cutting-edge veterinary diagnostics facility to strengthen its presence in the region. Antech introduces to the UK its first comprehensive veterinary diagnostics solution, encompassing reference laboratory services, in-lab diagnostics, advanced imaging, technology solutions, telemedicine services, and pioneering rapid diagnostics. [Published On: 2023-11-07]
IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing
IDEXX Laboratories, Inc. has introduced a diagnostic test designed to detect kidney injury in cats and dogs, the IDEXX Cystatin B Test. This significant advancement addresses a critical need in pet healthcare, as roughly one-third of kidney issues managed by veterinarians involve injury, often challenging to diagnose due to ambiguous symptoms. The IDEXX Cystatin B Test, alongside the existing IDEXX SDMA and other renal health tests, seeks to offer a comprehensive kidney health evaluation, enabling early intervention and improved treatment outcomes. [Published On: 2023-06-15]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Veterinary Diagnostic Equipment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Veterinary Diagnostic Equipment Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert N.V., Agrolabo S.p.A., Bio-Rad Laboratories, Inc., BioChek B.V., Biomerieux SA, Carestream Health Inc., Covetrus, Inc., Diagnostic Imaging Systems, Inc., Heska Corporation, Hill-Rom Holdings, Inc., IDEXX Laboratories, Inc., IM3 Inc., IMV Technologies group, INDICAL Bioscience GmbH, Innovative Diagnostics SAS, Merck & Co., Inc., Mindray Medical International Ltd., MinXray, Inc., Neogen Corporation, Randox Laboratories, Ltd., scil animal care company GmbH, Thermo Fisher Scientific, Inc., Virbac, Inc., and Zoetis, Inc..
Market Segmentation & Coverage